Rekvina Laboratories
add_icon

Rekvina Laboratories

49.75
+0.97
(1.99%)
Market Cap
55.28 Cr
PE Ratio
-157.35
Volume
1,146.00
Day High - Low
49.75 - 49.75
52W High-Low
48.78 - 6.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
55.28 Cr
EPS
-0.42
PE Ratio
-157.35
PB Ratio
14.04
Book Value
3.47
EBITDA
-0.25
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.27
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
positive
Rekvina Laboratories Limited has completed the acquisition of 100% of Radiant Parenterals Limited through a preferential allotment of 50.87 lakh equity shares. The deal involves a ₹4.62 crore share swap and a ₹46 lakh cash issuance.
neutral
Acquirers Surbhit Shah, Amit Shah, and Dhruval Patel accepted 14.41 lakh shares in Rekvina Laboratories' open offer at ₹10 each. The offer was only half-subscribed, leaving the public shareholding above the minimum threshold.
neutral
Acquirers Surbhit Mukesh Shah, Amit Mukesh Shah and Dhruvalkumar Patel have launched an open offer to acquire 26% of Rekvina Laboratories Limited at ₹10 per share.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,984.80
#1 4,76,220.00
38.02
#1 61,673.90
12.69
#1 11,565
26.53
64.24
9,467.00
2,51,319.10
84.13
11,067.00
13.95
2,568
65.50
83.63
5,066.00
1,92,694.36
88.83
13,886.20
20.34
2,138
3.28
59.56
1,161.30
1,16,853.95
25.78
27,657.90
17.64
5,026
-34.90
55.25
1,409.20
1,13,841.56
34.14
29,044.60
2.24
3,870
-39.18
41.30
1,915.00
1,03,382.54
95.90
6,867.80
22.01
890
#1 123.93
69.25
2,188.40
1,00,060.77
#1 17.92
29,038.90
#1 26.75
5,356
16.00
34.31
2,419.20
99,911.99
47.69
14,636.40
14.85
1,938
29.13
48.63
1,717.00
98,792.38
25.59
34,145.20
5.56
3,503
25.21
68.89
1,154.40
96,354.20
30.88
35,058.60
3.90
4,158
-69.10
37.89
Growth Rate
Revenue Growth
-
Net Income Growth
150.00 %
Cash Flow Change
-1,800.00 %
ROE
391.31 %
ROCE
391.31 %
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
0
0
0
0
0
0
0
0
0
0
1
2
Expenses
0
0
0
0
0
0
0
0
0
0
2
2
EBITDA
0
-0
0
-0
0
-0
-0
0
0
-0
-0
-0
Operating Profit %
15 %
-90 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-20 %
-19 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
0
-0
0
-0
-0
0
0
-0
-0
-0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-0
0
-0
0
-0
-0
0
0
-0
-0
-0
EPS in ₹
0.01
-0.09
-0.03
-0.13
0.00
-0.11
-0.13
0.00
-0.03
-0.23
-0.42
-0.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
2026
Total Assets
1
1
1
1
0
0
0
0
0
0
1
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
Current Assets
0
0
1
1
0
0
0
0
0
0
1
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
4,583
0
0
0
Other Assets
1
1
1
1
0
0
0
-4,583
0
0
0
Total Equity & Liabilities
1
1
1
1
0
0
0
0
0
0
1
Current Liabilities
0
0
0
0
0
0
0
0
0
0
1
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
2
Total Equity
1
1
1
0
0
0
0
0
-0
-0
-1
Reserve & Surplus
-3
-3
-3
-3
-3
-3
-3
-3
-3
-3
-4
Share Capital
3
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
0
0
0
0
0
Investing Activities
0
0
-0
0
0
0
0
0
0
Operating Activities
0
0
0
0
0
0
0
0
-0
Financing Activities
0
0
0
0
0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Aug 2026
Promoter
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
41.30 %
77.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
51.97 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.98 %
51.97 %
51.97 %
51.97 %
47.58 %
44.08 %
45.96 %
45.99 %
45.99 %
45.88 %
45.86 %
18.96 %
Others
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.73 %
6.74 %
6.74 %
6.74 %
11.12 %
14.62 %
12.74 %
12.71 %
12.71 %
12.82 %
12.85 %
4.04 %
No of Share Holders
0
0
2,434
2,433
2,438
2,440
2,440
2,440
2,440
2,440
2,440
2,440
2,432
2,431
2,430
2,430
2,427
2,426
2,427
503
2,475
2,465
2,457

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
12 Aug 2024 4.50 4.50
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 4.50 4.50
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 4.50 4.50
20 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Jan 2025 4.50 4.50
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 4.50 4.50
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 4.50 4.50
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 4.50 4.50
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 4.50 4.50
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 10.94 17.67
10 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
10 Apr 2026 29.78 39.09
21 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2026 40.91 35.09
13 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2026 25.00 33.82

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Aug 17, 2026
Clarification On Price MovementAug 14, 2026
FINANCIAL RESULTS QTR1Aug 13, 2026
Board Meeting Outcome for OUTCOME OF BOARD MEETINGAug 13, 2026
Clarification sought from Rekvina Laboratories LtdAug 12, 2026
Announcement under Regulation 30 (LODR)-AllotmentAug 12, 2026
Board Meeting Intimation for Consideration Of Unaudited Financial Result For The Quarter Ended 30Th June 2026Aug 01, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 01, 2026
Post Offer AdvertisementJul 31, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 30, 2026
Pre-Offer Advertisement & Corrigendum to Detailed Public StatementJun 30, 2026
Closure of Trading WindowJun 30, 2026
Updates on Open OfferJun 25, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 25, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 24, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 23, 2026
Letter of OfferJun 23, 2026
Financial Results For Quarter Ended & Year Ended On March 31 2026.May 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026May 21, 2026
Board Meeting Intimation for Consider And Approve Financial Result For The QTR 4May 18, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 10, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 10, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 06, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesApr 02, 2026
Draft Letter of OfferApr 02, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 24, 2026
Detailed Public StatementMar 24, 2026
Closure of Trading WindowMar 24, 2026
Shareholders Meeting -EGM 10.04.2026Mar 18, 2026
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferMar 17, 2026
Open OfferMar 16, 2026
Announcement under Regulation 30 (LODR)-Preferential IssueMar 16, 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMar 16, 2026
Board Meeting Outcome for Outcome Of Board MeetingMar 16, 2026
Board Meeting Intimation for PREFERENTIAL ISSUEMar 11, 2026
Financial Results For The Quarter And Nine Months Ended On 31St December 2025. Feb 09, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026Feb 06, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 29, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 29, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th February 2026Jan 29, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Closure of Trading WindowDec 26, 2025
Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations 2018 For The Half Year Ended On 30.09.2025.Nov 14, 2025
Standalone Financial Result For The Period Ended On 30 September 2025Nov 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November 2025Nov 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November 2025.Nov 05, 2025

Technical Indicators

RSI(14)
Overbought
86.27
ATR(14)
Less Volatile
1.65
STOCH(9,6)
Overbought
97.89
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.44
ADX(14)
Very Strong Trend
53.14
UO(9)
Bearish
83.69
ROC(12)
Uptrend And Accelerating
44.23
WillR(14)
Overbought
0.00